These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37285764)

  • 1. 15-Hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates hepatic abnormal lipid metabolism, ER stress, and inflammation through PGE
    Wang W; Liang M; Wang L; Bei W; Guo J
    Bioorg Chem; 2023 Aug; 137():106646. PubMed ID: 37285764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 15-hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates abnormal hepatic glucose metabolism through PGE
    Liang M; Wang L; Wang W
    Cell Signal; 2023 Aug; 108():110707. PubMed ID: 37164143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the Mechanisms of 15-PGDH Inhibitor SW033291 in Improving Type 2 Diabetes Mellitus: Insights from Metabolomics and Transcriptomics.
    Huang Y; Liang M; Liao Y; Ji Z; Lin W; Pu X; Wang L; Wang W
    Metabolites; 2024 Sep; 14(9):. PubMed ID: 39330516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 15-PGDH prevents ischemic renal injury by the PGE
    Kim HJ; Kim SH; Kim M; Baik H; Park SJ; Kang MS; Kim DH; Kim BW; Markowitz SD; Bae KB
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1054-F1066. PubMed ID: 33135478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rb1 Promotes Hepatic Glycogen Synthesis to Ameliorate T2DM Through 15-PGDH/PGE
    Liang M; Zhan W; Wang L; Bei W; Wang W
    Diabetes Metab Syndr Obes; 2023; 16():3223-3234. PubMed ID: 37867629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-Hydroxyprostaglandin dehydrogenase inhibitor prevents contrast-induced acute kidney injury.
    Kim BW; Kim HJ; Kim SH; Baik HJ; Kang MS; Kim DH; Markowitz SD; Kang SW; Bae KB
    Ren Fail; 2021 Dec; 43(1):168-179. PubMed ID: 33459127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 15-prostaglandin dehydrogenase attenuates acetaminophen-induced liver injury via suppression of apoptosis in liver endothelial cells.
    Shimada H; Yokotobi A; Yamamoto N; Takada M; Kawase A; Nakanishi T; Iwaki M
    Prostaglandins Leukot Essent Fatty Acids; 2024 Mar; 202():102640. PubMed ID: 39217773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flaxseed Oil Attenuates Hepatic Steatosis and Insulin Resistance in Mice by Rescuing the Adaption to ER Stress.
    Yu X; Deng Q; Tang Y; Xiao L; Liu L; Yao P; Tang H; Dong X
    J Agric Food Chem; 2018 Oct; 66(41):10729-10740. PubMed ID: 30145885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-C chemokine receptor 2 inhibitor ameliorates hepatic steatosis by improving ER stress and inflammation in a type 2 diabetic mouse model.
    Kim HM; Lee ES; Lee BR; Yadav D; Kim YM; Ko HJ; Park KS; Lee EY; Chung CH
    PLoS One; 2015; 10(3):e0120711. PubMed ID: 25816097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Prostaglandin-Degrading Enzyme 15-PGDH Mitigates Acute Murine Lung Allograft Rejection.
    Cui Y; Lv Z; Yang Z; Lei J
    Lung; 2023 Dec; 201(6):591-601. PubMed ID: 37934242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoplasmic reticulum-mitochondria miscommunication is an early and causal trigger of hepatic insulin resistance and steatosis.
    Beaulant A; Dia M; Pillot B; Chauvin MA; Ji-Cao J; Durand C; Bendridi N; Chanon S; Vieille-Marchiset A; Da Silva CC; Patouraux S; Anty R; Iannelli A; Tran A; Gual P; Vidal H; Gomez L; Paillard M; Rieusset J
    J Hepatol; 2022 Sep; 77(3):710-722. PubMed ID: 35358616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.
    Kammoun HL; Chabanon H; Hainault I; Luquet S; Magnan C; Koike T; Ferré P; Foufelle F
    J Clin Invest; 2009 May; 119(5):1201-15. PubMed ID: 19363290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin improves insulin resistance and hepatic steatosis in type 2 diabetes rats through activation of autophagy.
    Zhou W; Ye S
    Cell Biol Int; 2018 Sep; 42(10):1282-1291. PubMed ID: 29908010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.
    Yao L; Chen W; Song K; Han C; Gandhi CR; Lim K; Wu T
    PLoS One; 2017; 12(4):e0176106. PubMed ID: 28423012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Insights into Novel 15-Prostaglandin Dehydrogenase Inhibitors.
    Mallipeddi PL; Zhang Y; Li H; Markowitz SD; Posner B
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice.
    Kim DY; Kim SR; Jung UJ
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress.
    Oh H; Cho W; Abd El-Aty AM; Bayram C; Jeong JH; Jung TW
    Biochem Pharmacol; 2022 Sep; 203():115203. PubMed ID: 35948170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway.
    Cho IJ; Oh DH; Yoo J; Hwang YC; Ahn KJ; Chung HY; Jeong SW; Moon JY; Lee SH; Lim SJ; Jeong IK
    Sci Rep; 2021 May; 11(1):9894. PubMed ID: 33972568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats.
    Ma LL; Yuan YY; Zhao M; Zhou XR; Jehangir T; Wang FY; Xi Y; Bu SZ
    Chin J Nat Med; 2018 Jun; 16(6):411-417. PubMed ID: 30047462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Administration of
    Ren Z; Okyere SK; Xie L; Wen J; Wang J; Chen Z; Ni X; Deng J; Hu Y
    Front Immunol; 2022; 13():837237. PubMed ID: 35242140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.